ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Six More CCOPS In Funding Range For Recompetition

February 9, 1990

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

In Brief: House Appropriations Subcommitee Plans Hearing On NCI March 24; New DTP Director Sought

February 25, 1983

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994